- News & Analysis
- Home
- Latest News
- Reports
- Podcast
- The CVC Funding Round Database
- The CVC Directory
- University
- Video
- Subscribe
- Newsletters
- Events
Page 92
Spring Health secures $190m
Digital mental health platform Spring Health was valued at $2bn through a series C round backed by strategic investor Guardian Life.
Sep 17, 2021Amolyt shows ambition with $80m series B
The endocrine disease treatment developer pushed its overall funding past $160m in a round featuring Novo, Sham and Mass General Brigham.
Sep 17, 2021Prenetics tests out $1.25bn reverse merger
Genetic testing services provider Prenetics, a spinout of City University of Hong Kong, will hold a reverse merger at a $1.25bn valuation.
Sep 17, 2021Daily Deal Round Up: September 16, 2021
Immutable, Abra and Francis Medical have all raised more than $50m, while MAZ Systems has been acquired by Zype.
Sep 16, 2021Prenetics tests out $1.25bn reverse merger
Alibaba and Ping An-backed genetic testing services provider Prenetics will hold a reverse merger at a $1.25bn valuation, securing $120m in Pipe financing.
Sep 16, 2021Corporates coalesce in Rome’s series B
Sanofi Ventures, Mass General Brigham Ventures, GV and Alexandria Venture Investments have contributed to a $77m round for Rome Therapeutics.
Sep 16, 2021Daily Deal Round Up: September 15, 2021
Online furniture retailer Gaia, warehouse robot provider Locus Robotics, recruitment platform developer Canvas and ESG software producer Measurabl all raised $50m.
Sep 15, 2021Daily deal net: September 15, 2021
Every day, Global University Venturing rounds up the smaller investments from across the university innovation ecosystem in its deal net.
Sep 15, 2021Context Therapeutics frames IPO plans
Based on research at Drexel University, Context Therapeutics is seeking to raise up to $21m in an initial public offering on Nasdaq.
Sep 15, 2021Vanqua Bio wins over series B investors
Osage University Partners is among the investors in Northwestern spinout Vanqua Bio’s $85m series B round.
Sep 15, 2021About us
GCV provides the global corporate venturing community and their ecosystem partners with the information, insights and access needed to drive impactful open innovation. Across our three services - News & Analysis, Community & Events, and the GCV Institute - we create a network-rich environment for global innovation and capital to meet and thrive. At the heart of our community sits the GCV Leadership Society, providing privileged access to all our services and resources.
Navigation
test regLogin
Not yet subscribed?
We use cookies to enhance your browsing experience and analyse our traffic. By clicking "Accept All", you consent to our use of cookies. Accept Read MorePrivacy & Cookies PolicyPrivacy Overview
This website uses cookies to improve your experience while you navigate through the website. Out of these, the cookies that are categorized as necessary are stored on your browser as they are essential for the working of basic functionalities of the website. We also use third-party cookies that help us analyze and understand how you use this website. These cookies will be stored in your browser only with your consent. You also have the option to opt-out of these cookies. But opting out of some of these cookies may affect your browsing experience.Necessary cookies are absolutely essential for the website to function properly. This category only includes cookies that ensures basic functionalities and security features of the website. These cookies do not store any personal information.Any cookies that may not be particularly necessary for the website to function and is used specifically to collect user personal data via analytics, ads, other embedded contents are termed as non-necessary cookies. It is mandatory to procure user consent prior to running these cookies on your website.


